sion-451
sion-451: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Sionna Therapeutics, Inc. (SION) | Phase 1 |
Clinical Trials (1)
A Phase 1 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses and Multiple Ascending Doses of SION-451, and Multiple Dose Combinations of SION-451 and Complementary Modulators SION-2222 and SION-109 in Healthy Participants.
Frequently asked questions
Who is developing sion-451?
sion-451 is being developed by Sionna Therapeutics, Inc..
How many clinical trials involve sion-451?
BioSniper tracks 1 clinical trial involving sion-451.
Get deeper analysis on sion-451
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis